tert-butyl N-(3-aminobutan-2-yl)carbamate | 1334494-06-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: tert-butyl N-(3-aminobutan-2-yl)carbamate
• CAS: 1334494-06-2
• 化学式: C₉H₂₀N₂O₂
• 分子量: 188.27
• InChiKey: FUICJLZUPZOTSL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  64.4
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY
  申请人：IFM Due, Inc.

  公开号：US20220024919A1

  公开（公告）日：2022-01-27

  This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that inhibit (e.g., antagonize) Stimulator of Interferon Genes (STING). Said chemical entities are useful, e.g., for treating a condition, disease or disorder in which increased (e.g., excessive) STING activation (e.g., STING signaling) contributes to the pathology and/or symptoms and/or progression of the condition, disease or disorder (e.g., cancer) in a subject (e.g., a human). This disclosure also features compositions containing the same as well as methods of using and making the same.

  本公开涉及化学实体（例如，一种化合物或药用可接受的盐，和/或水合物，和/或共晶体，和/或该化合物的药物组合），其抑制（例如，对抗）干扰素基因激活器（STING）。所述化学实体可用于治疗一种情况、疾病或障碍，其中增加（例如，过度）STING激活（例如，STING信号传导）导致该情况、疾病或障碍的病理和/或症状和/或进展（例如，癌症）在受试者（例如，人类）中。本公开还涉及包含相同化学实体的组合物，以及使用和制备相同的方法。
• SYNTHETIC POLYMERS AND METHODS OF MAKING AND USING THE SAME
  申请人：Battelle Memorial Institute

  公开号：US20160257785A1

  公开（公告）日：2016-09-08

  Disclosed herein are monomer embodiments that can be used to make polymers, such as homopolymers, heteropolymers, and that can be used in particular embodiments to make sequence-defined polymers. Also disclosed herein are methods of making polymers using such monomer embodiments. Methods of using the polymers disclosed herein also are described.

  本文揭示了可用于制造聚合物的单体实施例，例如同聚物、异聚物，并且可以用于特定实施例中制造序列定义的聚合物。本文还揭示了使用此类单体实施例制造聚合物的方法。还描述了使用本文所揭示的聚合物的方法。
• Indazole containing macrocycles and therapeutic uses thereof
  申请人：Samumed, LLC

  公开号：US10759799B2

  公开（公告）日：2020-09-01

  Indazole macrocycle compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an indazole macrocycle compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.

  本发明公开了用于治疗各种疾病和病理的吲唑大环化合物。更具体地说，本发明涉及一种吲唑大环化合物或其类似物在治疗以 Wnt 通路信号激活为特征的疾病（如癌症、异常细胞增殖、血管生成、纤维化疾病、骨或软骨疾病以及骨关节病）中的用途、癌症、异常细胞增殖、血管生成、纤维化疾病、骨或软骨疾病和骨关节炎）、调节由 Wnt 通路信号介导的细胞事件以及由于 Wnt 通路和/或一种或多种 Wnt 信号成分的突变或失调引起的遗传性疾病和神经系统病症/紊乱/疾病。此外，还提供了治疗 Wnt 相关疾病状态的方法。
• US9365676B2
  申请人：——

  公开号：US9365676B2

  公开（公告）日：2016-06-14
• US9562137B2
  申请人：——

  公开号：US9562137B2

  公开（公告）日：2017-02-07